期刊文献+

羊传染性脓疱病毒湖北分离株CBP二级结构及其细胞表位的预测 被引量:2

PREDICTION OF THE SECONDARY STRUCTURE AND EPITOPES OF CHEMOKINE-BINDING PROTEIN OF ORF VIRUS HUBEI STRAIN
下载PDF
导出
摘要 参照GenBank中羊传染性脓疱病毒(Orf virus,ORFV)的毒力因子趋化因子结合蛋白(chemokine-binding protein,CBP)基因的核苷酸序列设计合成1对特异性引物,以羊传染性脓疱病毒湖北分离毒株的DNA为模板,提取总DNA。采用PCR方法特异扩增该基因片段,得到CBP基因序列。通过网络平台的SOPMA服务器和DNAStar软件预测ORFV CBP蛋白的二级结构;综合利用DNAStar软件、二级结构预测及ABCpred方案预测羊ORFV CBP蛋白的B细胞表位;分别采用人工神经网络法(ANNA)和在线程序预测ORFV CBP蛋白的细胞毒性T细胞和辅助T细胞的抗原表位。结果显示,ORFV CBP蛋白的二级结构主要包括α-螺旋、β-转角、无规则卷曲和β-片层4种类型,分别为α-螺旋占24.64%、β-片层占22.14%、β-转角占3.39%、无规则卷曲占49.29%;有7个优势B细胞表位,7个细胞毒性T细胞表位和3个辅助T细胞表位。本研究为ORFV诊断方法的建立、单克隆抗体的制备及表位疫苗的研制提供了理论依据。 According to the published chemokine-binding protein (CBP) gene sequence of Orf virus in the GenBank, a pair of primers were designed and synthesized for amplification in PCR using total DNA of Orf virus Hubei strain as template. The PCR products of the CBP gene were sequenced. Subsequently, the secondary structure of the CBP protein was predicted using the network platform SOPMA server and DNAStar software. The B cell epitopes of the CBP protein were predicted by comprehensive utilization of the DNAStar software, the secondary structure prediction and ABCpred program. The cytotoxic T cell and T helper epitopes of the CBP protein were predicted using the artificial neural network (ANNA) and online program. The results showed that the CBP protein of Orf virus was composed withα-helixes (24.64%),β-sheet (22.14%), random coils (49.29%) andβ-turn (3.39%). Prediction of epitomes revealed that the CBP protein had 7 B cell epitopes, 7 cytotoxic T cell epitopes and 3 T helper epitopes. The information obtained from these predictions provided theoretical foundations for development of diagnostic methods and vaccines as well as preparation of monoclonal antibodies against Orf virus.
出处 《中国动物传染病学报》 CAS 2014年第3期19-25,共7页 Chinese Journal of Animal Infectious Diseases
关键词 羊传染性脓疱病毒 毒力因子趋化因子结合蛋白 二级结构 细胞表位 预测 Orf virus chemokine-binding protein secondary structure epitope prediction
  • 相关文献

参考文献14

  • 1Haig D M, Mercer A A. Ovine diseases. Orf[J]. Vet Res, 1997, 29(3-4): 311-326.
  • 2De La Concha-Bermejillo A. Guo J, Zhang Z, et al. Severe persistent orf in young goats[J]. J Vet Diagn Invest, 2003, 15(5): 423-431.
  • 3Haig D M, Thomson J, Mclnnes C J, et al. A comparison of the anti-inflammatory and immuno-stimulatory activities of orf virus and ovine interleukin-10[J]. Virus Res, 2002, 90(1): 303-316.
  • 4Seer B T, McCaughan C A, Handel T M, et al. Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors[J]. Proc Natl Acad Sci U S A, 2003, 100(25): 15137-15142.
  • 5Florea L, Halldorsson B, Kohlbacher O, et al. Epitopeprediction algorithms for peptide-based vaccine design[C]//Bioinformatics Conference, 2003. CSB 2003. Proceedings of the 2003 IEEE. IEEE, 2003: 17-26.
  • 6Geourjon C, Deleage G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments[J]. Comput Appl Biosci, 1995, 11(6): 681-684.
  • 7Bhasin M, Raghava G P S. Prediction of CTL epitopes using QM, SVM and ANN techniques[J]. Vaccine, 2004, 22(23): 3195-3204.
  • 8Petersen T N, Brunak S, von Heijne G, et al. SignalP 4.0: discriminating signal peptides from transmembrane regions[J]. Nat Methods, 2011, 8(10): 785-786.
  • 9Saha S, Raghava G P S. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network[J]. Proteins, 2006, 65(1): 40-48.
  • 10Cottone R, Btittner M, Bauer B, et al. Analysis of genomic rearrangement and subsequent gene deletion of the attenuated Orf virus strain D1701[J]. Virus Res, 1998, 56(1): 53-67.

二级参考文献19

  • 1Ko J,Lee YH,Hwang SY,et al.Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization[J].Oncogene,2003,22(30):4679-4689.
  • 2Yoon SK,Lim NK,Ha SA,et al.The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma[J].Cancer Res,2004,64(15):5434-5441.
  • 3Jung SS,Park HS,Lee IJ,et al.The HCCR oncoprotein as a biomarker for human breast cancer[J].Clin Cancer Res,2005,11(21):7700-7708.
  • 4Shin SM,Chung YJ,Oh ST,et al.HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis[J].Gastroenterology,2006,130(7):2074-2086.
  • 5Chung YJ,Kim JW.Novel oncogene HCCR:Its diagnostic and therapeutic implications for cancer[J].Histol Histopathol,2005,20(3):999-1003.
  • 6Montgomerie S,Sundararaj S,Gallin WJ,et al.Improving the accuracy of protein secondary structure prediction using structural alignment[J].BMC Bioinformatics,2006,7:301.
  • 7Geourjon C,Deleage G.SOPMA:significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments[J].Comput Appl Biosci,1995,11(6):681-684.
  • 8Larsen MV,Lundegaard C,Kasper L,et al.An integrative approach to CTL epitope prediction:A combined algorithm integrating MHC class I binding,TAP transport efficiency,and proteasomal cleavage predictions[J].Eur J Immunol,2005,35(8):2295-2303.
  • 9Panagiotopoulos C,Qin H,Tan R,et al.Identification of a β-cell-specific HLA class I Restricted epitope in type 1 diabetes[J].Diabetes,2003,52(11):2647-2651.
  • 10方钟,罗文新,夏宁邵.表位疫苗研究进展[J].中国生物工程杂志,2007,27(11):86-91. 被引量:10

共引文献10

同被引文献26

  • 1Jiang M, Yao J, Feng G. Protective effect of DNA vaccine encoding Pseudomon: exotoxin A and PcrV against acute pulmonary P. aeruginosa infection [ J ]. PLoS ONE ,2014,9 (5) : e96609.
  • 2Sugawara E, Nagano K, Nikaido H. Ahemative folding pathways of the major porin OprF of Pseudomonas aeruginosa [ J ]. FEBS J, 2012,279(6) :910 -918.
  • 3Westritschnig K, Hochreiter R, Wallner G, et al. A randomized, pla- cebo -controlled phase I study assessing the safety and immuno- genieity of a Pseudomonas aeruginosa hybrid outer membrane pro- tein OprF/I vaccine ( IC43 ) in healthy volunteers[ J]. Hum Vaccin Immunother,2014,10( 1 ) :170 - 183.
  • 4Quigley K, Reynolds C, Goudet A, et al. Chronic unfection by mu- eoid Pseudomonas aeruginosa associated with dysregulation in T - cell immunity to outer membrane porin F [ J ]. Am J Respir Crit Care Med,2015,191 ( 11 ) :1250 - 1264.
  • 5Cui Z, Han D, Sun X, et al. Mannose - modified ehitosan micro- spheres enhance OprF - OprI - mediated protection of mice against Pseudomonas aeruginosa infection via induction of mueosal immuni- ty [ J ]. Appl Microbiol Biotechnol, 2015,99 ( 2 ) : 667 - 680.
  • 6Krause A, Whu W Z, Qiu J, et al. RGD capsid modification en- hances mucosal protective immunity of a non - human primate ade- novirus vector expressing Pseudomonas aeruginosa OprF [ J ]. Clin Exp Immuno1,2013,173 (2) :230 - 241.
  • 7Amat - Ur - Rasool H, Saghir A, Idrees M. Computational predic- tion and analysis of envelop glycoprotein epitopes of DENV - 2 and DENV -3 pakistani isolates:a first step towards dengue vac- cine development [ J]. PLoS ONE ,2015,10( 3 ) : e0119854.
  • 8Manzano - Romdn R, Diaz - Martin V, Oleaga A, et al. Identifica- tion of protective finear B - cell epitopes on the subolesin/akirin orthologues of Ornithodoros spp. soft ticks [ J ]. Vaccine, 2015,33 (8) :1046 - 1055.
  • 9Chen H, Yang H, Wei J F, et al. In silico prediction of the T - cell and IgE - binding epitopes of pera 6 and blag 6 allergens in cock- roaches[J]. Mol Med Rep,2014,10(4) :2130 -2136.
  • 10Saha S, Raghava G P. Prediction of continuous B - cell epitopes in an antigen using recurrent neural network [ J ]. Proteins, 2006,65 (1) :40-48.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部